Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-2-microglobulin-associated amyloidosis

J Floege1, G Ehlerding

  • 1Department of Medicine, Division of Nephrology, Hannover Medical School, Germany.

Nephron
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-dependent lipid profile inversely associates with mortality in hemodialysis patients - independent of inflammation/malnutrition.

Journal of internal medicine·2021
Same author

Heart failure in advanced chronic kidney disease: treatment rationale.

Herz·2021
Same author

[Immunoglobulin A nephropathy].

Der Internist·2019
Same author

[What is certain in the treatment of glomerulonephritis?]

Der Internist·2018
Same author

[Choosing wisely recommendations in nephrology].

Der Internist·2017
Same author

[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].

Der Internist·2017
Same journal

The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

Nephron·2026
Same journal

Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

Nephron·2026
Same journal

Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

Nephron·2026
Same journal

Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

Nephron·2026
Same journal

Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

Nephron·2026
Same journal

Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

Nephron·2026
See all related articles

Beta2-microglobulin amyloidosis is a complication of long-term dialysis, but not with kidney transplants. This review covers its causes, symptoms, and treatments for end-stage renal disease patients.

Area of Science:

  • Nephrology
  • Internal Medicine

Background:

  • Beta2-microglobulin amyloidosis is a significant complication in patients undergoing long-term renal replacement therapy.
  • This condition primarily affects individuals on non-transplant dialysis treatments.

Observation:

  • The syndrome does not occur in patients with a functioning kidney transplant.
  • Existing amyloidosis does not progress further post-transplantation.

Findings:

  • Affects most end-stage renal disease patients on dialysis for over 15 years.
  • Contributes to significant morbidity and, rarely, mortality.

Implications:

  • Highlights the protective effect of kidney transplantation against beta2-microglobulin amyloidosis.
  • Emphasizes the need for understanding pathogenesis, diagnosis, and management strategies.

Related Experiment Videos